Oncogene activation by fusion of chromosomes in leukaemia
Adams, J.M.
Nature 315(6020): 541-542
1985
ISSN/ISBN: 0028-0836 PMID: 4010771 Document Number: 246462
Document emailed within 1 workday
Related Documents
Ishizaka, Y.; Ochiai, M.; Tahira, T.; Sugimura, T.; Nagao, M. 1989: Activation of the ret-II oncogene without a sequence encoding a transmembrane domain and transforming activity of two ret-II oncogene products differing in carboxy-termini due to alternative splicing Oncogene 4(6): 789-794Crossen, P.E.; Morrison, M.J. 1992: XbaI RFLP of ETS-1 oncogene in chronic B-cell leukaemia Leukemia 6(8): 843-844
Canaani, E.; Gale, R.P.; Steiner-Saltz, D.; Berrebi, A.; Aghai, E.; Januszewicz, E. 1984: Altered transcription of an oncogene in chronic myeloid leukaemia Lancet 1(8377): 593-595
O'Riordan, M.L.; Robinson, J.A.; Buckton, K.E.; Evans, H.J. 1971: Distinguishing between the chromosomes involved in Down's syndrome (trisomy 21) and cronic myeloid leukaemia (Ph1) by fluorescence Nature 230(5290): 167-168
Ghysdael, J.; Beug, H. 1992: The leukaemia oncogene v-erbA: a dominant negative version of ligand dependent transcription factors that regulates red cell differentiation? Cancer Surveys 14: 169-180
Casson, A.G.; Mukhopadhyay, T.; Cleary, K.R.; Ro, J.Y.; Levin, B.; Roth, J.A. 1991: Oncogene activation in esophageal cancer Journal of Thoracic and Cardiovascular Surgery 102(5): 707-709
Wu, S.Q.; Voelkerding, K.V.; Sabatini, L.; Chen, X.R.; Huang, J.; Meisner, L.F. 1995: Extensive amplification of bcr/abl fusion genes clustered on three marker chromosomes in human leukemic cell line K-562 Leukemia 9(5): 858-862
Garicochea, B.; Chase, A.; Lazaridou, A.; Goldman, J.M. 1994: T lymphocytes in chronic myelogenous leukaemia (CML): no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients Leukemia 8(7): 1197-1201
Rodenhuis, S.; Slebos, R.J. 1992: Clinical significance of ras oncogene activation in human lung cancer Cancer Research 52(9 Suppl): 2665s-2669s
Von Heimendahl, G.; Gebhart, E.; Dingermann, T. 1988: Proto-oncogene activation in surgical specimens of rectal carcinoma Anticancer Research 8(4): 805-811
Mu, H.J.; Xie, R.; Shen, Y.F.; Jiang, Y.Q.; Zeng, Y.J. 2009: Cadherin-13 in primary and blast crisis chronic myeloid leukaemia: declining expression and negative correlation with the BCR/ABL fusion gene British Journal of Biomedical Science 66(1): 20-24
Mölders, H.; Defesche, J.; Müller, D.; Bonner, T.I.; Rapp, U.R.; Müller, R. 1985: Integration of transfected LTR sequences into the c-raf proto-oncogene: activation by promoter insertion EMBO Journal 4(3): 693-698
Bernard, C.; Mougin, C.; Laurent, R.; Lab, M. 1994: Oncogene activation: an informative marker for the human papillomavirus-lesions severity Cancer Detection and Prevention 18(4): 273-282
Sirinian, M.I.; Marchetti, A.; Di Rocco, G.; Starace, G.; Jucker, R.; Nasi, S. 1993: Ras oncogene transformation of human B lymphoblasts is associated with lymphocyte activation and with a block of differentiation Oncogene 8(1): 157-163
Dean, M.; Kent, R.B.; Sonenshein, G.E. 1983: Transcriptional activation of immunoglobulin alpha heavy-chain genes by translocation of the c-myc oncogene Nature 305(5933): 443-446
Mangues, R.; Seidman, I.; Gordon, J.W.; Pellicer, A. 1992: Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice Oncogene 7(10): 2073-2076
Longati, P.; Bardelli, A.; Ponzetto, C.; Naldini, L.; Comoglio, P.M. 1994: Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor) Oncogene 9(1): 49-57
Newbold, R.F. 1985: Malignant transformation of mammalian cells in culture: delineation of stages and role of cellular oncogene activation Iarc Scientific Publications 67: 31-53
Yamasaki, H.; Hollstein, M.; Cabral, J.R.; Tomatis, L. 1989: Role of oncogene activation during prenatal (transplacental) initiation and postnatal promotion of mouse skin tumours Iarc Scientific Publications 96: 221-237
Hashimoto, Y.; Kawachi, E.; Shudo, K.; Sekiya, T. 1986: Activation of c-Ha-ras proto-oncogene by in vitro chemical modification with 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole (Glu-P-1) and 4-nitroquinoline N-oxide (4NQO) Nucleic Acids Symposium Series 17: 135-138